Drugs / Calcium polycarbophil
Calcium polycarbophil
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01252524 | Oct 2010 → Apr 2011 | type 2 diabetes mellitus | East Carolina University | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Calcium polycarbophil | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01252524 ↗ |
| Known as | Polycarbophil calcium | ChEMBL registry synonym — accepted as the source's own label CHEMBL2109032 ↗ |
| Known as | WI 140 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2109032 ↗ |
| Known as | WL 140 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2109032 ↗ |
| Modality | Small molecule | — CHEMBL2109032 ↗ |
| Route | Oral | “calcium polycarbophil 625 mg po TID before each meal with 8 oz water for 6 months” NCT01252524 ↗ |